• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

GE unveils new cardiovascular ultrasound

Article

At this month’s Society of Echocardiography meeting in Chicago, GE Medical Systems showed a new cardiovascular ultrasound system named the Vivid FiVe. GE officials said this is the first ultrasound system on the market to offer a myocardial

At this month’s Society of Echocardiography meeting in Chicago, GE Medical Systems showed a new cardiovascular ultrasound system named the Vivid FiVe. GE officials said this is the first ultrasound system on the market to offer a myocardial tissue visualization technique called “tissue tracking.”

The tool aids cardiologists in the diagnosis and monitoring of coronary artery disease.

Vivid FiVe was preceded by the Vingmed System FiVe in GE’s line of cardiovascular ultrasound products, and is an upgrade to this system. The Vivid FiVe includes three new features: tissue tracking, contrast imaging with real-time myocardial contrast, and four-dimensional imaging.

Tissue tracking provides more accurate imaging of the heart, contrast imaging allows clinicians to study myocardial perfusion, and 4-D imaging occurs when clinicians apply 2-D digital data to construct a 4-D model of cardiac functions.

Related Videos
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.